Page last updated: 2024-08-23

levamisole and Nephrosis, Lipoid

levamisole has been researched along with Nephrosis, Lipoid in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19906 (54.55)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's1 (9.09)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Azukaitis, K; Hodson, EM; Palmer, SC; Strippoli, GF1
Manabe, S; Nagata, M; Nitta, K1
Ammar, HM; Donia, AF; El-Agroudy, Ael-B; Moustafa, Fel-H; Sobh, MA1
Angjeleska, M; Gucev, Z; Petrusevska, G; Ristoska-Bojkovska, N; Tasic, V1
Gordillo Paniagua, G; Urdaneta Carruyo, E; Zúñiga Armendariz, V1
Ahmed, HA; Amer, GM; Donia, AF; Gazareen, SH; Ismail, AM; Khamis, S; Moustafa, FE; Shoeib, AA; Sobh, MA1
Miller, PF1
Tejani, A1
Mongeau, JG; Robitaille, PO; Roy, F1
Dayal, R; Elhence, BR; Mathur, P; Prasad, R; Sharma, R; Singh, K1
Ali, U; Kolhatkar, U; Kutty, M; Mehta, KP1

Reviews

2 review(s) available for levamisole and Nephrosis, Lipoid

ArticleYear
Interventions for minimal change disease in adults with nephrotic syndrome.
    The Cochrane database of systematic reviews, 2022, 03-01, Volume: 3

    Topics: Acute Kidney Injury; Adult; Calcineurin Inhibitors; Child; Female; Humans; Immunosuppressive Agents; Levamisole; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Recurrence; Steroids

2022
Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
    Contributions to nephrology, 2018, Volume: 195

    Topics: Abatacept; Adjuvants, Immunologic; Calcineurin Inhibitors; Everolimus; Glomerulonephritis; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Levamisole; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Podocytes; Ribonucleosides; Rituximab; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases

2018

Trials

2 trial(s) available for levamisole and Nephrosis, Lipoid

ArticleYear
Long-term results of two unconventional agents in steroid-dependent nephrotic children.
    Pediatric nephrology (Berlin, Germany), 2005, Volume: 20, Issue:10

    Topics: Child; Cyclophosphamide; Drug Administration Schedule; Female; Glucocorticoids; Humans; Injections, Intravenous; Levamisole; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Remission Induction; Retreatment; Time Factors; Treatment Outcome

2005
[Therapeutic trial with levamisole in children with idiopathic minimal change nephrotic syndrome].
    Boletin medico del Hospital Infantil de Mexico, 1983, Volume: 40, Issue:2

    Topics: Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Levamisole; Male; Nephrosis, Lipoid; Prednisone; Prospective Studies; Random Allocation

1983

Other Studies

7 other study(ies) available for levamisole and Nephrosis, Lipoid

ArticleYear
Autoimmune thyroiditis in a child with steroid-dependent nephrotic syndrome.
    European journal of pediatrics, 2009, Volume: 168, Issue:2

    Topics: Adjuvants, Immunologic; Autoantibodies; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Levamisole; Nephrosis, Lipoid; Prednisone; Recurrence; Thyroid Gland; Thyroiditis, Autoimmune

2009
Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Pediatric nephrology (Berlin, Germany), 2002, Volume: 17, Issue:5

    Topics: Adjuvants, Immunologic; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levamisole; Male; Nephrosis, Lipoid; Prospective Studies; Recurrence; Remission Induction; Steroids

2002
Immunoregulatory treatment for minimal change nephrotic syndrome.
    Archives of disease in childhood, 1986, Volume: 61, Issue:7

    Topics: Humans; Levamisole; Nephrosis, Lipoid; T-Lymphocytes, Regulatory

1986
Relapsing nephrotic syndrome.
    Nephron, 1987, Volume: 45, Issue:2

    Topics: Captopril; Chlorambucil; Cyclophosphamide; Cyclosporins; Glomerular Mesangium; Humans; Immune Complex Diseases; Immunity, Cellular; Immunoglobulin M; Levamisole; Lymphokines; Nephrosis, Lipoid; Nephrotic Syndrome; Recurrence; Steroids

1987
Clinical efficacy of levamisole in the treatment of primary nephrosis in children.
    Pediatric nephrology (Berlin, Germany), 1988, Volume: 2, Issue:4

    Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Levamisole; Male; Nephrosis, Lipoid; Prednisone; Recurrence

1988
Effect of levamisole on T cell in minimal change nephrotic syndrome.
    Indian pediatrics, 1988, Volume: 25, Issue:12

    Topics: Female; Humans; Levamisole; Male; Nephrosis, Lipoid; Rosette Formation; T-Lymphocytes

1988
Immunoregulatory treatment for minimal change nephrotic syndrome.
    Archives of disease in childhood, 1986, Volume: 61, Issue:2

    Topics: B-Lymphocytes; Child; Child, Preschool; Humans; Immunoglobulins; Immunosuppression Therapy; Infant; Leukocyte Count; Levamisole; Lymphocyte Activation; Nephrosis, Lipoid; Phytohemagglutinins; T-Lymphocytes

1986